Refine by
Industries served
- Medical / Health Care
- Chemical & Pharmaceuticals
- Environmental
- Manufacturing, Other
- Automobile & Ground Transport
- Defense
- Electronics and Computers
- Aerospace & Air Transport
- Waste and Recycling
- Oil, Gas & Refineries
- Monitoring and Testing
- Health and Safety
- Air and Climate
- University / Academia / Research
- Government
- Food and Beverage
Depressive Disorder Suppliers & Manufacturers
30 companies found
based inLodi, ITALY
IBSA Farmaceutici, part of the Institute Biochimique SA Group, has its headquarter in Lodi, two manufacturing plants near Milan and three R&D labs which contribute to the Made in Italy’s success. More than 500 people are employed in Italy. IBSA ...
Endocrinology is the branch of medicine that studies the endocrine system, placing particular emphasis on diseases of the glands responsible for the internal secretion and transfer to the blood of the hormones that govern bodily functions. Amongst ...
based inKyiv, UKRAINE
Darnitsa is the leader of the Ukrainian market in physical terms. 90 years of experience and GMP production certification have allowed us to earn confidence in 16 countries worldwide. We produce 180 products with a focus on cardiology, neurology, ...
Symbiia® - for treatment of major depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety ...
based inNew Haven, CONNECTICUT (USA)
BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company utilizing artificial intelligence, or AI, approaches to develop transformative medicines in neuroscience and immuno-oncology. We are focused on utilizing cutting-edge ...
It is being investigated for at-home use for the acute treatment of agitation in bipolar and schizophrenia patients, for agitation in Alzheimer’s disease, and as an adjunctive treatment for major depressive ...
based inLos Angeles, CALIFORNIA (USA)
NeuroSigma is a California-based life sciences company established to develop bioelectronic technologies with the potential to transform medical practice and patients' lives. NeuroSigma is focused on TNS neuromodulation therapies based on ...
based inGeneva, SWITZERLAND
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available, small molecule drugs known as allosteric modulators for neurological disorders. Allosteric ...
mGlu2 NAM for the treatment of mild neurocognitive disorders, or mNCD. We are developing mGlu2 NAM as a novel orally available treatment for mNCD associated with Alzheimer’s disease, Parkinson’s disease and ...
based inBellevue, WASHINGTON (USA)
EMulate Therapeutics is a clinical-stage therapeutic device company utilizing its patented proprietary radio frequency energy (RFE) technology, targeted at the low and ultra-low ends of the RFE spectrum (ulRFE®), to provide safe and effective ...
based inErkrath, GERMANY
Since 1996, the H. Buschkuehl Ltd. company is engaged in the distribution of innovative medical and health equipment and products. The 'flagship', which is the original of the photon therapy, the Bionic 880, was awarded with the (German) industry ...
based inAustin, TEXAS (USA)
Paradromics stands as a leader in advanced brain-computer interface (BCI) technology, focusing on converting real-time neural data into applications that support brain-health and communication. Established with strong collaborations from ...
The Tempo Brain-State Monitor is a brain-computer interface (BCI) developed by Paradromics, specifically designed to aid mental health treatment through real-time brain state monitoring. It offers a novel approach by providing timely, data-driven ...
based inSaint Paul, MINNESOTA (USA)
Biomedix is a provider of front-line diagnostic solutions for delivering value-based care. We offer a mobile health assessment platform that centralizes data for analyzing population health across multiple chronic conditions, and supports a variety ...
based inPrinceton, NEW JERSEY (USA)
Otsuka Pharmaceutical Co., Ltd. is a global healthcare company with the corporate philosophy: “Otsuka–people creating new products for better health worldwide.” Otsuka researches, develops, manufactures, and markets innovative products, with a focus ...
After it is swallowed, ABILIFY MYCITE® (aripiprazole tablets with sensor) sends a tiny signal to a wearable Bluetooth®* patch that connects with your smartphone, allowing you to see your daily data all in one ...
based inMalmö, SWEDEN
At Flow Neuroscience we develop a new kind of depression treatment which combines an easy-to-use brain stimulation headset with an engaging, personalized mobile app to target both the physical and behavioural elements of major depressive disorder ...
based inHelsinki, FINLAND
Nexstim was established in 2000 to commercialise the opportunity of adding navigation to an existing transcranial magnetic stimulation (TMS) technology. The founders believed that navigation and making the TMS visible with the help of navigation is ...
based inNew York, NEW YORK (USA)
We develop, validate, and commercialize software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are ...
Click is researching multiple cognitive exercises for the treatment of ...
based inWilloughby Hills, OHIO (USA)
Neuros Medical, a bioelectric medical technology company headquartered in Aliso Viejo, CA and with offices in Cleveland, Ohio, developed the Altius System for the critical purpose of alleviating chronic post-amputation pain and restoring quality of ...
A growing amputee population: There are over two million people estimated to be living with limb loss in the United States today, and almost 185,000 people have an amputation each year.1 Causes of amputation include peripheral vascular disease, ...
based inCambridge, MASSACHUSETTS (USA)
Sage is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health, and our ...
The human brain is a network of billions of nerve cells, connected in complex electrical circuits to communicate. Brain health and function depend on these circuits. The flow of information among these circuits is managed by neural regulatory ...
based inBurlington, MASSACHUSETTS (USA)
BrainsWay focuses on developing cutting-edge medical devices that help advance the level of treatment offered to patients. To do so, BrainsWay’s advanced flagship technology of Deep Transcranial Magnetic Stimulation (Deep TMS) is expanding the ...
based inMississauga, ONTARIO (CANADA)
Award-winning, Clinical Stage/Life-Sciences company focused on the drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors. The company is targeting anxiety, depression, ...
The Endocannabinoid System is a complex system within the body that sends signals to the cells. There are three major parts to the system, enzymes, receptors, and endocannabinoids. The body makes these molecules. Endocannabinoids are similar to ...
based inChantilly, VIRGINIA (USA)
Arthus Biosystems is pleased to provide a series of research reagents and kits to help carry out scientific investigations related to methionine cycle, the critical biochemical pathway that is conserved throughout evolution in all organisms. Our SAM ...
based inWixom, MICHIGAN (USA)
HumHealth Chronic Care Management solution helps practices provide non-face-to-face care to the patients with chronic conditions. Physicians can provide care management by phone or by other means and capture the time spent on managing care for ...
based inMalvern, PENNSYLVANIA (USA)
NeuroStar is the market leader in Transcranial Magnetic Stimulation technology for the treatment of Major Depressive Disorder. Based in Malvern, PA, we are a public medical device company (STIM) focused on developing non-invasive therapies for ...